![Dmitry Popov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Dmitry Popov
Fundador en Maxwell Asset Management LLC (Private Equity) .
Perfil
Dmitry Popov is the founder and managing partner of Maxwell Asset Management LLC, a private equity firm founded in 2008.
He is currently the Chief Executive Officer of MYR GmbH.
Cargos activos de Dmitry Popov
Empresas | Cargo | Inicio |
---|---|---|
Maxwell Asset Management LLC (Private Equity)
![]() Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | Fundador | 01/01/2008 |
MYR GmbH
![]() MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Maxwell Asset Management LLC (Private Equity)
![]() Maxwell Asset Management LLC (Private Equity) Investment ManagersFinance Maxwell Asset Management LLC /Private Equity/ (Maxwell Asset Management) is the private equity and venture capital subsidiary of Maxwell Capital Group LLC. The firm was founded by Dmitry Popov in 2008. It is headquartered in Moscow, Russia with an additional office in Boston, USA. | Finance |
MYR GmbH
![]() MYR GmbH BiotechnologyHealth Technology MYR GmbH engages in operating an biotechnology company. It focuses on the development and commercialization of therapeutics for the treatment of chronic hepatitis B (HBV) and D (HDV) infections. The company was founded by Joern Moeller and Alexander Alexandrov in 2010 and is headquartered in Bad Homburg, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Dmitry Popov